Mouse-human hybridoma which produces antivirus-human antibody, process for preparation thereof, and antivirus-human monoclonal antibody
AssigneeTeijin Limited
InventorsYasuhiko Masuho, Yoh-ichi Matsumoto, Toru Sugano, Katsuhiko Tomibe
Life of this patent
Estimating the term…
Abstract
Mouse-human hybridoma, which produces monoclonal antivirus-human antibody reactive to herpes simplex virus, varicella zoster virus, and cytomegalo virus, obtained by allowing a human antibody cell, which is sensitized to virus or protein or glycoprotein arising from virus, to fuse with a mouse myeloma cell in the presence of mitogen in vitro.
Claims11
Mouse-human hybridoma and a cell line arising therefrom both of which produce antivirus-human antibody, obtained by fusing a human antibody producing cell which has been sensitized in vitro with virus of the Herpesvirus family or protein or glycoprotein from said virus in the presence of mitogen with a mouse myeloma cell.
Human monoclonal antibody which reacts specifically to varicella zoster virus, wherein the antibody is antibody V2 which recognizes glycoprotein antigens of varicella zoster virus which glycoprotein is gpI having a molecular weight of 90K and 545K.
Human monoclonal antibody which reacts specifically to varicella zoster virus, wherein the antibody recognizes glycoprotein antigens of varicella zoster virus which glycoprotein is gpI having a molecular weight of 90K and 55K.
A process for preparing mouse-human hybridoma which produces antivirus-human antibody comprising the steps of:
- sensitizing a human antibody-producing cell in vitro in the presence of mitogen to virus of the Herpesvirus family or protein or glycoprotein arising from said virus, and
- fusing said human antibody-producing cell with a mouse myeloma cell.
Dependencies are inferred from the claim text.